FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold medications. Here's what you need to know.
FDA proposes ending use of popular decongestant in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Ineffective cough syrup ingredient should be axed officially, FDA says
A panel last year said it found evidence the ingredient, used in many popular medicines, did not aid with nasal congestion.
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off the market. Phenylephrine in many popular over-the-counter cold and allergy medications,
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."
FDA says some cold and allergy drugs have an ineffective key ingredient
There are new concerns that phenylephrine, an ingredient in common over-the-counter cold and allergy medicines is ineffective. The FDA said the ingredient is safe but many popular medicines are being pulled off the shelves.
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular over-the-counter decongestants - from the market, citing evidence that it doesn't work.
FDA considers pulling some cold medicine
FDA considers pulling some cold medicine
health enews1d
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
Hosted on MSN4h
These Over-The-Counter Decongestants Don't Work, FDA Says
This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely ...
GlobalData on MSN6h
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...